1 |
Waisundara, V. Y., M. Huang, A. Hsu, D. Huang, and B. K. Tan. 2008. Characterization of the anti-diabetic and antioxidant effects of rehmannia glutinosa in streptozotocin-induced diabetic wistar rats. Am. J. Chin. Med. 36, 1083-1104.
DOI
|
2 |
Wild, S. and C. D. Byrne. 2004. The role of treatment to increase HDL-cholesterol and decrease triglyceride concentrations in prevention of coronary heart disease in Type 2 diabetes. Diabet Med. 21, 8-11.
|
3 |
Woo, W. S., K. H. Shin, H. Wangner, and H. Lotter. 1987. The structure of macelignan from Myristica fragrans. Phytochemistry 26, 1542.
DOI
|
4 |
Yamahara, J., T. Yamada, T. Kitani, Y. Naitoh, and H. Fujimura. 1989. Antianoxic action and active constituents of evodiae fructus. Chem. Pharm. Bull. (Tokyo) 37, 1820-1822.
DOI
ScienceOn
|
5 |
Yamauchi, T., J. Kamon, H. Waki, Y. Terauchi, N. Kubota, K. Hara, Y. Mori, T. Ide, K. Murakami, N. Tsuboyama-Kasaoka, O. Ezaki, Y. Akanuma, O. Gavrilova, C. Vinson, M. L. Reitman, H. Kagechika, K. Shudo, M. Yoda, Y. Nakano, K. Tobe, R. Nagai, S. Kimura, M. Tomita, P. Froguel, and T. Kadowaki. 2001. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 7, 941-916.
DOI
|
6 |
Shafrir, E. 1992. Animal models of non-insulin-dependent diabetes. Diabetes Metab. Rev. 8, 179-208.
DOI
|
7 |
Shokuhin, K. H. 2000. Market trend of health foods and health ingredients. Shokhin to Kaihatsu 35, 18-34.
|
8 |
Steinmetz, A. 2003. Treatment of diabetic dyslipoproteinemia. Exp Clin Endocrinol Diabetes. 111, 239-245.
DOI
|
9 |
Suneetha, W. J. and T. P. Krishnakantha. 2005. Cardamom extract as inhibitor of human platelet aggregation. Phytotherapy Research 19, 437-440.
DOI
|
10 |
Stumvoll, M., B. J. Goldstein, and T. W. van Haeften. 2005. Type 2 diabetes: principles of pathogenesis and therapy. Lancet 365, 1333-1346.
DOI
|
11 |
Thorens, B. Glucose sensing and the pathogenesis of obesity and type 2 diabetes. 2008. Int. J. Obes. (Lond) 32, S62-S71.
|
12 |
Tominaga, M., H. Eguchi, H. Manaka, K. Igarashi, T. Kato, and A. Sekikawa. 1999. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetic Care 22, 920-946.
DOI
|
13 |
Turner, R. C., C. A. Cull, V. Frighi, and R. R. Holman. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. 1999. JAMA 281, 2005-2012.
DOI
|
14 |
Wagner, A. M., A. Perez, J. L. Sanchez-Quesada, J. Ordonez-Llanos. 2005. Triglyceride-to-HDL cholesterol ratio in the dyslipidemic classification of type 2 diabetes. Diabetes Care 28, 1798-1800.
DOI
|
15 |
Lee, Y. M., D. K. Kim, S. H. Kim, T. Y. Shin, and H. M. Kim. 1996. Antianaphylactic activity of Poncirus trifoliata fruit extract. J. Ethnopharmacol. 54, 77-84.
DOI
ScienceOn
|
16 |
Lim, J. I. 2003. Recent research trends of diabetes drug. Health Industry and Technology Trends Spring. 28-38.
|
17 |
Medical Economics Company. 2000. PDR for herbal medicine. 984.
|
18 |
Park, I. B. and S. H. Baik. 2009. Epidemiologic characteristics of diabetes mellitus in Korea: current status of diabetic patients using Korean health insurance database. Korean Diabetes J. 33. 357-362.
DOI
|
19 |
Ministry of Health, 2009. Welfare and Family Affairs; Korea Centers for Disease Control and Prevention: The 4th national health and nutrition examination survey. Seoul, Korea Centers for Disease Control and Prevention.
|
20 |
Moon, E. J., Y. E. Jo, T. C. Park, Y. K. Kim, S. H. Jung, H. J. Kim, D. J. Kim, Y. S. Chung, and K. W. Lee. 2008. Clinical characteristics and direct medical costs of type 2 diabetic patients. Korean Diabetes J. 32. 358-365.
DOI
|
21 |
Park, S. K., M. K. Park, J. H. Suk, M. K. Kim, Y. K. Kim, I. J. Kim, Y. H. Kang, K. J, Lee, H. S. Lee, C. W. Lee, B. H. Kim, K. I. Lee, M. K. Kim, and D. K. Kim. 2009. Cause-of-Death trends for diabetes mellitus over 10 years. Korean Diabetes J. 33. 65-72.
DOI
|
22 |
Rai, P. K., D. Jaiswal, S. Mehta, and G. Watal. 2009. Anti-hyperglycaemic potential of Psidium guajava raw fruit peel. Indian J. Med. Res. 2009. 129, 561-565.
|
23 |
Scott, D. K., R. M. O'Doherty., J. M. Stafford., C. B. Newgard, and D. K. Granner. 1998. The repression of hormone-activated PEPCK gene expression by glucose is insulin-independent but requires glucose metabolism. J. Biol. Chem. 273, 24145-24151.
DOI
|
24 |
Jin, D. Q., C. S. Lim, J. K. Hwang, I. Ha, and J. S. Han. 2005. Anti-oxidant and anti-inflammatory activities of macelignan in murine hippocampal cell line and primary culture of rat microglial cells. Biochem. Biophys. Res. Commun. 331, 1264-1269.
DOI
|
25 |
Khan, B., M. S. Arayne, S. Naz, and N. Mukhtar. 2005. Hypogylcemic activity of aqueous extract of some indigenous plants. Pak. J. Pharm. Sci. 18, 62-64.
|
26 |
Klein, R., B. E. Klein, S. E. Moss, M. D. Davis, and D. L. DeMets.1988. Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy. JAMA 260, 2864-2871.
DOI
|
27 |
Kim, K. J. and Y. N. Han. 2002. Lignans from Myristica fragrans. Yakhak Hoeji 46, 98-101.
과학기술학회마을
|
28 |
Kim, S. H., E. J. Shin, and C. K. Hyun. 2005. Enhancing effect of extracts of phellodendri cortex on glucose uptake in normal and insulin-resistant 3T3-L1 adipocytes. Kor. J. Pharmacogn. 36, 291-298.
과학기술학회마을
|
29 |
Kim, S. H., D. H. Lee, S. H. Kwon, B. H. Lim, S. H. Lee, and B. C. Min. 2007. Isolation and quantitative determination method validation of myristicin from Myristica fragrans Houttuyn. Kor. J. Pharmacogn. 38, 19-21.
과학기술학회마을
|
30 |
Korea Pharmaceutical Traders Association. 2000. Korea Drug Test Laboratory Chinese medicine (herb) REGULATION. 370.
|
31 |
Korean Diabetes Association, Health Insurance Review & Assessment Service. 2008. Report of Task Force Team for Basic Statistical Study of Korean Diabetes Mellitus: Diabetes in Korea 2007. 1st ed., Goldfishery, Seoul. Korea.
|
32 |
Lee, J. Y., Y. B. Han, W. S. Woo, and K. H. Shin. 1990. Antioxidant activity of diarylbutanes. Kor. J. Pharmacogn. 21, 270-273.
과학기술학회마을
|
33 |
Faraj, M., G. Beauregard, A. Tardif, E. Loizon, A. Godbout, K. Cianflone, H. Vidal, and R. Rabasa-Lhoret. 2008. Regulation of leptin, adiponectin and acylation-stimulating protein by hyperinsulinaemia and hyperglycaemia in vivo in healthy lean young men. Diabetes Metab. 34, 334-342.
DOI
|
34 |
Han, K. L., J. S. Choi, J. Y. Lee., J. Song, M. K. Joe., M. H. Jung, and J. K. Hwang. 2008. Therapeutic potential of peroxisome proliferators-activated receptor-alpha/gamma dual agonist with alleviation of endoplasmic reticulum stress for the treatment of diabetes. Diabetes 57, 737-745.
DOI
ScienceOn
|
35 |
Fasshauer, M. and R. Paschke. 2003. Regulation of adipocytokines and insulin resistance. Diabetologia 46, 1594-1603.
DOI
|
36 |
Flyvbjerg, A., L. Denner, B. F. Schrijvers, R. G. Tilton, T. H. Mogensen, S. R. Paludan, and R. Rasch. 2004. Long-term renal effects of a neutralizing RAGE antibody in obese type 2 diabetic mice. Diabetes 53, 166-172.
DOI
|
37 |
Friedman, J. E., Y. Sun, T. Ishizuka, C. J. Farrell, S. E. McCormack, L. M., Herron, P. Hakimi, P. Lechner, and J. S. Yun. 1997. Phosphoenolpyruvate carboxykinase (GTP) gene transcription and hyperglycemia are regulated by glucocorticoids in genetically obese db/db transgenic mice. J. Biol. Chem. 272, 31475-31481.
DOI
ScienceOn
|
38 |
International Diabetes Federation. 2003. International Diabetes Federation: Diabetes Atla. pp. 17-71, 2nd eds., Belgium.
|
39 |
Jeong, H. J., H. Y. Kwon, J. T. Han, Y. J. Kim, and A. K. Lee. 2008. Cost-effectiveness analysis of type 2 DM screening program of national health insurance corporation. Kor. J. Health Economics and Policy 14, 29-50.
|
40 |
American Institute of Nutrition: Report of Ad Hoc Committee on Standards for Nutritional Studies. 1980. J. Nutr. 110, 1717-1726.
|
41 |
American Institute of Nutrition: Report of the American Institute of Nutrition ad hoc Committee on Standards for Nutritional Studies. 1977. J. Nutr. 107, 1340-1348.
|
42 |
Coleman1, D. L. 1978. Obese and diabetes: Two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia 14, 141-147
DOI
|
43 |
Crapo, P. A., G. Reaven, and J. Olefsky. 1977. Postprandial plasma-glucose and -insulin responses to different complex carbohydrates. Diabetes 26, 1178-1183.
DOI
|
44 |
Doda, R. F. 1996. Diabetes mellitus in clinical chemistry, pp. 613-641, In Kaplan, L. A., J. P. Amadeo (eds.), Mosby-Year Book. St Louis, Mo.
|
45 |
Duarte, N. L., S. Colagiuri, T. Palu, X. L. Wang, D. E. Wilcken. 2003. Obesity, Type II diabetes and the Ala54Thr polymorphism of fatty acid binding protein 2 in the Tongan population. Mol. Genet. Metab. 79, 183-188.
DOI
|